What a 31% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Lucía Berenguer
Page 11 of 18 of this archive, newest first.
Archive — page 11
356 piecesWhat a 13% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What changed at CPC in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at SGN in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 32% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What a 41% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What a 32% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
The last mile is the warmest mile
The honest finding is more nuanced than the alarm: a lyophilised cake tolerates a brief warm excursion far better than a reconstituted solution does, and the trade’s real…
What changed at GL Biochem in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 32% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
The empty half of every certificate of analysis
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
What changed at WXT in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at CPC in December, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 27% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What changed at QSC in December, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The specification sheet says 500,000. The report says conforms.
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
Errors ranked by how much dose they move
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be structural.
What an 11% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
What changed at QYB in December, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A guide to the results that will resolve themselves
The panel drawn during a week of vomiting is measuring the vomiting.